Kezar Life Sciences, Inc. (KZR)

Kezar Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.75	35.49	40.46	62.88	21.23
Short-Term Investments	90.5	165.88	236.11	145.47	119.22
Cash & Short-Term Investments	132.25	201.37	276.56	208.36	140.45
Cash Growth	-34.33%	-27.19%	32.73%	48.35%	79.59%
Other Receivables	0.42	2.29	0.77	-	0.77
Receivables	0.42	2.29	0.77	-	0.77
Prepaid Expenses	1.09	1.22	1.12	2.57	2.73
Other Current Assets	3.73	2.07	7.27	0.73	0.87
Total Current Assets	137.49	206.95	285.72	211.65	144.81
Property, Plant & Equipment	4.78	8.69	13.17	6	6.75
Other Long-Term Assets	2.42	5.6	0.67	0.28	0.28
Total Assets	144.68	221.24	299.57	217.93	151.84
Accounts Payable	3.65	8.25	2.48	2.03	2.36
Accrued Expenses	7.94	6.48	5.95	4.99	3.04
Current Portion of Long-Term Debt	5.22	-	-	-	-
Current Portion of Leases	3.53	3.01	2.57	1.2	1.04
Total Current Liabilities	20.33	17.74	11	8.21	6.44
Long-Term Debt	5.11	10.07	9.83	9.62	-
Long-Term Leases	2.33	5.85	8.87	3.22	4.42
Total Liabilities	27.77	33.67	29.7	21.06	10.86
Common Stock	0.01	0.01	0.07	0.06	0.05
Additional Paid-In Capital	551.57	538.46	519.62	377.77	267.09
Retained Earnings	-434.5	-350.76	-248.89	-180.65	-126.02
Comprehensive Income & Other	-0.16	-0.13	-0.92	-0.29	-0.14
Total Common Equity	116.92	187.57	269.87	196.88	140.98
Shareholders' Equity	116.92	187.57	269.87	196.88	140.98
Total Liabilities & Equity	144.68	221.24	299.57	217.93	151.84
Total Debt	16.18	18.93	21.26	14.04	5.46
Net Cash (Debt)	116.07	182.44	255.3	194.31	134.98
Net Cash Growth	-36.38%	-28.54%	31.39%	43.95%	87.89%
Net Cash Per Share	15.92	25.15	37.90	36.83	30.68
Filing Date Shares Outstanding	7.31	7.28	7.08	5.67	4.81
Total Common Shares Outstanding	7.3	7.28	6.85	5.63	4.64
Working Capital	117.16	189.21	274.73	203.44	138.37
Book Value Per Share	16.01	25.77	39.40	34.99	30.41
Tangible Book Value	116.92	187.57	269.87	196.88	140.98
Tangible Book Value Per Share	16.01	25.77	39.40	34.99	30.41
Machinery	5.85	5.84	4.67	3.67	2.91
Leasehold Improvements	3.49	3.49	3.37	3.27	3.27

Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q